Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (326)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
86
2026
3082
9.780
Why?
Antibodies, Bispecific
13
2025
108
4.070
Why?
B-Cell Maturation Antigen
9
2025
101
2.390
Why?
Immunotherapy, Adoptive
7
2025
163
1.900
Why?
Hematopoietic Stem Cell Transplantation
8
2024
610
1.850
Why?
Humans
102
2026
53230
1.320
Why?
Bone Marrow
11
2024
359
1.280
Why?
Neoplasm, Residual
7
2025
171
1.270
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
123
1.270
Why?
Leukemia, Plasma Cell
2
2020
35
1.230
Why?
Neoplasms, Plasma Cell
3
2024
35
1.210
Why?
Paraproteinemias
2
2022
72
1.200
Why?
Positron-Emission Tomography
5
2025
298
1.140
Why?
Neoplasm Recurrence, Local
10
2025
647
1.120
Why?
Myelodysplastic Syndromes
6
2026
87
1.060
Why?
Aged
33
2026
10429
1.050
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
1.030
Why?
Immunoglobulin Light Chains
2
2017
90
0.940
Why?
Prognosis
18
2025
2118
0.900
Why?
Transplantation, Autologous
9
2024
488
0.890
Why?
Middle Aged
32
2026
13419
0.880
Why?
Gene Expression Regulation, Neoplastic
10
2024
868
0.870
Why?
Immunoglobulins, Intravenous
1
2025
64
0.860
Why?
Immunoconjugates
2
2022
37
0.820
Why?
Mutation
8
2022
1337
0.820
Why?
Male
40
2026
27435
0.790
Why?
Adult
28
2026
14534
0.770
Why?
Antibodies, Monoclonal
6
2023
477
0.760
Why?
Leukemia, Myeloid, Acute
4
2019
208
0.720
Why?
Gene Expression Profiling
11
2025
1112
0.720
Why?
Aged, 80 and over
14
2026
3494
0.700
Why?
Health Personnel
1
2024
259
0.700
Why?
Signal Transduction
7
2026
1748
0.680
Why?
Testis
1
2021
74
0.650
Why?
Female
36
2026
28782
0.640
Why?
Tumor Microenvironment
5
2024
274
0.620
Why?
Hematopoietic Stem Cells
3
2019
189
0.610
Why?
Plasma Cells
6
2025
234
0.610
Why?
Quality of Life
1
2025
902
0.600
Why?
Cell Proliferation
8
2023
1031
0.600
Why?
Clonal Evolution
4
2024
59
0.590
Why?
Gene Expression
3
2018
618
0.580
Why?
Drug Resistance, Neoplasm
3
2026
350
0.570
Why?
DNA Methylation
5
2026
592
0.540
Why?
Clinical Trials as Topic
6
2023
466
0.530
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1043
0.520
Why?
Translocation, Genetic
5
2021
266
0.510
Why?
Thoracic Neoplasms
1
2016
12
0.480
Why?
Plasmacytoma
1
2016
45
0.470
Why?
Receptors, Interleukin-8B
1
2015
5
0.460
Why?
Survival Analysis
8
2024
659
0.450
Why?
Interleukin-8
1
2015
85
0.440
Why?
Antineoplastic Agents
8
2026
1232
0.430
Why?
Recurrence
7
2025
694
0.410
Why?
Receptors, G-Protein-Coupled
2
2024
58
0.410
Why?
Cell Line, Tumor
9
2026
1470
0.390
Why?
Combined Modality Therapy
4
2024
640
0.380
Why?
Fluorodeoxyglucose F18
5
2021
182
0.380
Why?
Neutropenia
2
2023
113
0.370
Why?
Neoplasms, Second Primary
2
2024
75
0.350
Why?
Oncogene Proteins, Fusion
2
2018
62
0.350
Why?
Chromosomes, Human, Pair 1
3
2023
95
0.340
Why?
Polycomb Repressive Complex 2
2
2021
48
0.340
Why?
Stem Cell Transplantation
3
2022
191
0.330
Why?
Evolution, Molecular
2
2021
97
0.330
Why?
Epigenesis, Genetic
4
2020
412
0.330
Why?
Tretinoin
1
2010
53
0.310
Why?
Treatment Outcome
10
2025
5595
0.310
Why?
Risk Assessment
4
2024
1368
0.300
Why?
Transcription Factors
3
2023
571
0.300
Why?
Transcriptome
3
2025
367
0.290
Why?
Immunoglobulin kappa-Chains
2
2021
22
0.290
Why?
Disease Progression
8
2025
880
0.280
Why?
DNA-Binding Proteins
2
2021
423
0.270
Why?
Retrospective Studies
9
2026
6819
0.270
Why?
Neoplasm Proteins
3
2020
330
0.270
Why?
Melanoma
1
2010
277
0.260
Why?
Pyrimidines
2
2026
205
0.260
Why?
RANK Ligand
2
2024
188
0.240
Why?
Pyrimethamine
1
2026
1
0.240
Why?
Cytomegalovirus
1
2026
42
0.240
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
92
0.240
Why?
Cytomegalovirus Infections
1
2026
49
0.230
Why?
Virus Activation
1
2026
49
0.230
Why?
Biopsy
2
2018
600
0.230
Why?
Mice
8
2026
5982
0.230
Why?
Skin Neoplasms
1
2010
500
0.230
Why?
Radiopharmaceuticals
3
2021
198
0.230
Why?
Chemokine CCL3
1
2024
12
0.220
Why?
HMGB1 Protein
1
2024
22
0.220
Why?
Dexamethasone
3
2024
429
0.220
Why?
T-Lymphocytes
5
2024
321
0.220
Why?
Kaplan-Meier Estimate
3
2021
487
0.210
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.210
Why?
Chemokine CXCL12
1
2024
35
0.210
Why?
Antigens, CD19
1
2024
29
0.210
Why?
Mutation Rate
2
2021
36
0.200
Why?
Bone Resorption
2
2024
304
0.200
Why?
Genome-Wide Association Study
1
2024
184
0.200
Why?
Risk Factors
9
2026
4017
0.200
Why?
Myeloproliferative Disorders
1
2023
31
0.200
Why?
Cell Cycle
2
2021
237
0.200
Why?
Sulfonamides
2
2026
139
0.200
Why?
Neoplasm Staging
2
2024
774
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.190
Why?
Genomics
2
2023
271
0.190
Why?
Animals
10
2026
13526
0.180
Why?
Drug Approval
1
2022
41
0.180
Why?
Osteolysis
1
2022
74
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
Qualitative Research
1
2024
384
0.180
Why?
Osteocytes
1
2024
227
0.180
Why?
Lymphoma, B-Cell
1
2022
60
0.180
Why?
Polymorphism, Single Nucleotide
1
2024
505
0.180
Why?
Bone Marrow Transplantation
1
2022
110
0.180
Why?
Hematologic Diseases
1
2021
21
0.180
Why?
Epigenomics
1
2021
76
0.170
Why?
Patient Participation
1
2022
72
0.170
Why?
Genetic Predisposition to Disease
1
2024
533
0.170
Why?
Chromosome Deletion
2
2023
138
0.170
Why?
Abnormal Karyotype
1
2021
6
0.170
Why?
Drug Design
2
2013
121
0.170
Why?
Myeloma Proteins
1
2021
26
0.170
Why?
Immunoglobulin A
1
2021
46
0.170
Why?
Communicable Diseases
1
2021
54
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2022
238
0.170
Why?
Hematologic Neoplasms
1
2022
101
0.170
Why?
Xenograft Model Antitumor Assays
2
2026
228
0.160
Why?
Genes, Tumor Suppressor
2
2021
73
0.160
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.160
Why?
Salvage Therapy
1
2021
138
0.160
Why?
Practice Guidelines as Topic
1
2023
502
0.160
Why?
Immunoglobulin G
1
2021
192
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Bone Diseases
1
2021
94
0.160
Why?
Neoplasm Invasiveness
1
2021
281
0.160
Why?
Gene Amplification
1
2019
58
0.150
Why?
Chromosomal Instability
1
2019
16
0.150
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Atrial Fibrillation
1
2022
197
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.150
Why?
United States
3
2024
5409
0.140
Why?
Comorbidity
1
2021
638
0.140
Why?
Models, Statistical
1
2020
229
0.140
Why?
Healthcare Disparities
1
2022
312
0.140
Why?
Spleen
1
2019
166
0.140
Why?
Spinal Fractures
1
2018
37
0.140
Why?
Disease Models, Animal
3
2026
1517
0.140
Why?
Phosphotransferases
1
2018
18
0.140
Why?
Bacteremia
1
2019
87
0.140
Why?
Adipocytes
1
2018
131
0.140
Why?
Cell Differentiation
3
2022
681
0.130
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Disease-Free Survival
4
2019
466
0.130
Why?
Kidney Function Tests
1
2017
55
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Glomerular Filtration Rate
1
2017
128
0.130
Why?
Chromosome Aberrations
2
2023
297
0.130
Why?
Survival Rate
4
2020
949
0.130
Why?
Pelvis
1
2017
66
0.130
Why?
Histoplasma
1
2016
24
0.130
Why?
CA-125 Antigen
1
2016
16
0.120
Why?
Receptor, TIE-2
1
2016
16
0.120
Why?
HIV Infections
1
2021
402
0.120
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.120
Why?
Histoplasmosis
1
2016
48
0.120
Why?
Urea
1
2016
80
0.120
Why?
Indazoles
1
2016
47
0.120
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
92
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
Remission Induction
3
2024
221
0.120
Why?
Gastrointestinal Diseases
1
2016
130
0.110
Why?
Tumor Suppressor Protein p53
1
2017
228
0.110
Why?
Apoptosis
3
2026
1139
0.110
Why?
Proteasome Inhibitors
1
2016
104
0.110
Why?
Immunologic Factors
1
2016
117
0.110
Why?
Cell Cycle Checkpoints
1
2015
32
0.110
Why?
Time Factors
2
2021
2991
0.110
Why?
Kidney Diseases
1
2017
230
0.110
Why?
Cluster Analysis
1
2015
237
0.110
Why?
Thrombopoiesis
1
2014
5
0.110
Why?
Neoplastic Stem Cells
1
2015
90
0.110
Why?
Hydrazines
1
2014
19
0.110
Why?
Myocardium
1
2017
471
0.110
Why?
Benzoates
1
2014
22
0.110
Why?
Immunotherapy
1
2016
266
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Cell Survival
1
2015
600
0.100
Why?
Cross-Sectional Studies
3
2023
1723
0.100
Why?
Pyrazoles
1
2014
123
0.100
Why?
Chromosomes, Human, Pair 7
1
2012
29
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Flow Cytometry
2
2012
400
0.090
Why?
Cardiovascular Diseases
1
2017
501
0.090
Why?
STAT3 Transcription Factor
1
2012
89
0.090
Why?
Thalidomide
1
2014
378
0.090
Why?
Chromatin
2
2024
145
0.090
Why?
Cell Transformation, Neoplastic
1
2013
187
0.090
Why?
Follow-Up Studies
3
2024
2318
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
266
0.080
Why?
Leukemia, Promyelocytic, Acute
1
2010
11
0.080
Why?
Luciferases
1
2010
50
0.080
Why?
Response Elements
1
2010
29
0.080
Why?
Gene Silencing
1
2010
122
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Tumor Burden
2
2020
132
0.080
Why?
Transfection
1
2010
359
0.080
Why?
Recombinant Fusion Proteins
1
2010
175
0.080
Why?
Molecular Structure
1
2010
320
0.080
Why?
Histones
2
2021
318
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Syndecan-1
2
2021
73
0.070
Why?
Case-Control Studies
2
2024
1212
0.060
Why?
Tumor Cells, Cultured
2
2020
441
0.060
Why?
Imaging, Three-Dimensional
2
2017
145
0.060
Why?
Gene Expression Regulation
1
2010
1003
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.050
Why?
Mendelian Randomization Analysis
1
2024
7
0.050
Why?
ROC Curve
1
2025
246
0.050
Why?
Telomere
1
2024
38
0.050
Why?
Arkansas
2
2021
2068
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
34
0.050
Why?
Killer Cells, Natural
1
2024
113
0.050
Why?
Ferritins
1
2024
38
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
80
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
145
0.050
Why?
Antibodies
1
2024
147
0.050
Why?
B-Lymphocytes
1
2024
178
0.050
Why?
Demography
1
2023
91
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
52
0.050
Why?
Cell Communication
1
2023
73
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Neoplasms
1
2013
1334
0.050
Why?
Patients
1
2022
52
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
United States Food and Drug Administration
1
2022
93
0.040
Why?
Oncogenes
1
2021
61
0.040
Why?
Patient Selection
1
2023
273
0.040
Why?
Infant
1
2010
3805
0.040
Why?
Phylogeny
1
2022
231
0.040
Why?
Tomography, X-Ray Computed
2
2017
1180
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
110
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
17
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
Protein Kinase Inhibitors
1
2022
233
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Genetic Variation
1
2020
223
0.040
Why?
Health Status Disparities
1
2022
221
0.040
Why?
Multivariate Analysis
1
2021
598
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
180
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
29
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Syndrome
1
2019
248
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
630
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Protein-Tyrosine Kinases
1
2018
87
0.030
Why?
False Positive Reactions
1
2017
66
0.030
Why?
Bone and Bones
1
2021
501
0.030
Why?
Amino Acid Sequence
1
2018
563
0.030
Why?
Itraconazole
1
2016
37
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Databases, Factual
1
2020
742
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Amphotericin B
1
2016
105
0.030
Why?
Ileum
1
2016
88
0.030
Why?
NF-kappa B
1
2018
327
0.030
Why?
Intestinal Obstruction
1
2016
38
0.030
Why?
Glycolysis
1
2016
76
0.030
Why?
Colonoscopy
1
2016
107
0.030
Why?
Gene Knockdown Techniques
1
2016
109
0.030
Why?
Staphylococcal Infections
1
2019
271
0.030
Why?
Models, Genetic
1
2016
169
0.030
Why?
Genomic Instability
1
2016
88
0.030
Why?
Fever
1
2016
112
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
136
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
98
0.030
Why?
Logistic Models
1
2018
947
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
148
0.030
Why?
Heart
1
2017
350
0.030
Why?
Proportional Hazards Models
1
2016
445
0.030
Why?
Algorithms
1
2018
667
0.030
Why?
Echocardiography
1
2017
409
0.030
Why?
Weight Loss
1
2016
257
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Antifungal Agents
1
2016
350
0.030
Why?
Young Adult
1
2024
4511
0.030
Why?
Longitudinal Studies
1
2016
774
0.030
Why?
Models, Immunological
1
2013
8
0.020
Why?
Chemistry, Pharmaceutical
1
2013
35
0.020
Why?
Early Diagnosis
1
2013
84
0.020
Why?
Karyotyping
1
2012
77
0.020
Why?
Azacitidine
1
2012
39
0.020
Why?
Primary Cell Culture
1
2012
62
0.020
Why?
Cell Lineage
1
2012
90
0.020
Why?
Polymerase Chain Reaction
1
2013
452
0.020
Why?
Child
1
2024
7379
0.020
Why?
Enzyme Inhibitors
1
2013
371
0.020
Why?
Antigens, CD
1
2012
217
0.020
Why?
Magnetic Resonance Imaging
1
2017
1583
0.020
Why?
Cytokines
1
2013
627
0.020
Why?
Reproducibility of Results
1
2013
1219
0.020
Why?
Cohort Studies
1
2013
1557
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description